Rhumbline Advisers Has $12.07 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Rhumbline Advisers decreased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,293,794 shares of the pharmacy operator’s stock after selling 21,627 shares during the period. Rhumbline Advisers’ holdings in Walgreens Boots Alliance were worth $12,071,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the stock. First Financial Corp IN raised its position in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $26,000. TD Private Client Wealth LLC raised its holdings in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares in the last quarter. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $30,000. Finally, Eastern Bank acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $33,000. 58.59% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Royal Bank of Canada increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Finally, Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.63.

Walgreens Boots Alliance Stock Down 3.3 %

WBA stock opened at $10.16 on Monday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market capitalization of $8.78 billion, a price-to-earnings ratio of -0.99, a PEG ratio of 1.31 and a beta of 0.65. The business’s fifty day moving average price is $10.37 and its two-hundred day moving average price is $9.70.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.66 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.